logo1-color.png
Groundbreaking Voice of the Patient Report for pediatric low-grade glioma (pLGG) published by Pediatric Brain Tumor Foundation
August 07, 2024 09:30 ET | Pediatric Brain Tumor Foundation
Report documents the experiences of pLGG patients, survivors, their families, to inform future drug development for most common brain tumor type in kids
logo1-color.png
Ursula Burns, former Xerox CEO, and Jordan Wertlieb, EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board as inaugural members
June 25, 2024 10:24 ET | Pediatric Brain Tumor Foundation
Ursula Burns, former Xerox CEO, and Jordan Wertlieb EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board
logo1-color.png
The Pediatric Brain Tumor Foundation Welcomes Dr. Sanjay Gupta to its Board of Directors
May 01, 2024 09:00 ET | Pediatric Brain Tumor Foundation
The Pediatric Brain Tumor Foundation Welcomes Dr. Sanjay Gupta to its Board of Directors
logo1-color.png
Pediatric Brain Tumor Foundation celebrates FDA approval of Day One Biopharmaceuticals’ OJEMDA™, new treatment for common pediatric brain tumor type
April 29, 2024 15:30 ET | Pediatric Brain Tumor Foundation
Pediatric Brain Tumor Foundation celebrates FDA approval of Day One Biopharmaceuticals’ OJEMDA™, new treatment for common pediatric brain tumor type